药物对比
Fremanezumab vs Almotriptan
Compare Fremanezumab vs Almotriptan: CGRP antibody for prevention vs 5-HT agonist for acute migraines. See efficacy, safety, and when each is preferred.
此页面暂无可用的对比维度。
临床背景
Patients with frequent migraines evaluating a switch from acute triptan use to CGRP preventive therapy or combination treatment.
结论
Fremanezumab suits migraine prevention while Almotriptan targets acute attacks, so neither is inherently superior.
全部药物对比